PharmGen Science, Inc. (004720.KS)
KRW 4035.0
(0.62%)
KRW 4035.0
(0.62%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 532.33 Million KRW | 8.62% |
| 2022 | 490.11 Million KRW | -15.18% |
| 2021 | 577.85 Million KRW | -43.19% |
| 2020 | 1.01 Billion KRW | -28.74% |
| 2019 | 1.42 Billion KRW | 594.56% |
| 2018 | 205.5 Million KRW | -10.1% |
| 2017 | 228.59 Million KRW | -1.15% |
| 2016 | 231.25 Million KRW | -0.73% |
| 2015 | 232.94 Million KRW | -0.52% |
| 2014 | 234.16 Million KRW | -0.66% |
| 2013 | 235.71 Million KRW | 334.51% |
| 2012 | 54.24 Million KRW | -43.78% |
| 2011 | 96.49 Million KRW | -44.79% |
| 2010 | 174.78 Million KRW | -44.66% |
| 2009 | 315.84 Million KRW | -30.83% |
| 2008 | 456.59 Million KRW | -23.53% |
| 2007 | 597.1 Million KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - KRW | 0.0% |
| 2024 Q1 | 481.73 Million KRW | 0.0% |
| 2023 Q2 | 651.62 Million KRW | 27.03% |
| 2023 Q3 | 569.06 Million KRW | -12.67% |
| 2023 FY | 532.33 Million KRW | 8.62% |
| 2023 Q1 | 512.95 Million KRW | 4.66% |
| 2023 Q4 | 532.33 Million KRW | -6.45% |
| 2022 Q3 | 558.57 Million KRW | 23.25% |
| 2022 Q4 | 490.11 Million KRW | -12.26% |
| 2022 FY | 490.11 Million KRW | -15.18% |
| 2022 Q2 | 453.19 Million KRW | -12.01% |
| 2022 Q1 | 515.05 Million KRW | -10.87% |
| 2021 Q2 | 1.71 Billion KRW | 86.52% |
| 2021 Q4 | 577.85 Million KRW | -42.14% |
| 2021 FY | 577.85 Million KRW | -43.19% |
| 2021 Q3 | 998.77 Million KRW | -41.65% |
| 2021 Q1 | 917.62 Million KRW | -9.78% |
| 2020 FY | 1.01 Billion KRW | -28.74% |
| 2020 Q2 | 1.37 Billion KRW | 5.85% |
| 2020 Q1 | 1.3 Billion KRW | -8.73% |
| 2020 Q4 | 1.01 Billion KRW | -17.16% |
| 2020 Q3 | 1.22 Billion KRW | -10.96% |
| 2019 Q2 | 754.05 Million KRW | 35.39% |
| 2019 FY | 1.42 Billion KRW | 594.56% |
| 2019 Q4 | 1.42 Billion KRW | 59.37% |
| 2019 Q3 | 895.62 Million KRW | 18.78% |
| 2019 Q1 | 556.96 Million KRW | 171.03% |
| 2018 Q3 | 205.5 Million KRW | 0.0% |
| 2018 FY | 205.5 Million KRW | -10.1% |
| 2018 Q1 | 205.5 Million KRW | -10.1% |
| 2018 Q2 | 205.5 Million KRW | 0.0% |
| 2018 Q4 | 205.5 Million KRW | 0.0% |
| 2017 Q4 | 228.59 Million KRW | -0.43% |
| 2017 FY | 228.59 Million KRW | -1.15% |
| 2017 Q1 | 230.9 Million KRW | -0.15% |
| 2017 Q2 | 230.34 Million KRW | -0.24% |
| 2017 Q3 | 229.57 Million KRW | -0.33% |
| 2016 Q2 | 232.03 Million KRW | -0.22% |
| 2016 FY | 231.25 Million KRW | -0.73% |
| 2016 Q3 | 231.38 Million KRW | -0.28% |
| 2016 Q1 | 232.55 Million KRW | -0.17% |
| 2016 Q4 | 231.25 Million KRW | -0.06% |
| 2015 Q4 | 232.94 Million KRW | -0.12% |
| 2015 Q3 | 233.22 Million KRW | -0.07% |
| 2015 FY | 232.94 Million KRW | -0.52% |
| 2015 Q1 | 233.62 Million KRW | -0.23% |
| 2015 Q2 | 233.38 Million KRW | -0.1% |
| 2014 Q3 | 234.65 Million KRW | -0.18% |
| 2014 Q4 | 234.16 Million KRW | -0.21% |
| 2014 Q2 | 235.06 Million KRW | -0.15% |
| 2014 Q1 | 235.42 Million KRW | -0.12% |
| 2014 FY | 234.16 Million KRW | -0.66% |
| 2013 Q3 | 235.94 Million KRW | 14.48% |
| 2013 FY | 235.71 Million KRW | 334.51% |
| 2013 Q1 | 54.2 Million KRW | -0.08% |
| 2013 Q2 | 206.1 Million KRW | 280.22% |
| 2013 Q4 | 235.71 Million KRW | -0.1% |
| 2012 Q2 | 100.15 Million KRW | 1.85% |
| 2012 Q1 | 98.33 Million KRW | 1.9% |
| 2012 FY | 54.24 Million KRW | -43.78% |
| 2012 Q4 | 54.24 Million KRW | -47.31% |
| 2012 Q3 | 102.96 Million KRW | 2.8% |
| 2011 FY | 96.49 Million KRW | -44.79% |
| 2011 Q2 | 160.17 Million KRW | -85.04% |
| 2011 Q1 | 1.07 Billion KRW | 512.64% |
| 2011 Q4 | 96.49 Million KRW | -25.68% |
| 2011 Q3 | 129.84 Million KRW | -18.93% |
| 2010 FY | 174.78 Million KRW | -44.66% |
| 2010 Q1 | 315.84 Million KRW | 0.0% |
| 2010 Q2 | 246.44 Million KRW | -21.97% |
| 2010 Q3 | 211.74 Million KRW | -14.08% |
| 2010 Q4 | 174.78 Million KRW | -17.46% |
| 2009 Q2 | 386.24 Million KRW | -8.35% |
| 2009 Q1 | 421.43 Million KRW | -7.7% |
| 2009 Q4 | 315.84 Million KRW | -30.83% |
| 2009 Q3 | 456.59 Million KRW | 18.21% |
| 2009 FY | 315.84 Million KRW | -30.83% |
| 2008 Q3 | 491.74 Million KRW | -6.67% |
| 2008 Q2 | 526.87 Million KRW | -6.25% |
| 2008 FY | 456.59 Million KRW | -23.53% |
| 2008 Q4 | 456.59 Million KRW | -7.15% |
| 2008 Q1 | 561.99 Million KRW | -5.88% |
| 2007 Q2 | 18.53 Billion KRW | 89.24% |
| 2007 Q4 | 597.1 Million KRW | -96.5% |
| 2007 Q3 | 17.07 Billion KRW | -7.85% |
| 2007 FY | 597.1 Million KRW | 0.0% |
| 2007 Q1 | 9.79 Billion KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Daewoong Co., Ltd. | 93.41 Billion KRW | 99.43% |
| Wooridul Huebrain Limited | 213.88 Million KRW | -148.889% |